Skip to main content
. 2020 Oct 30;11:575391. doi: 10.3389/fmicb.2020.575391

TABLE 2.

Characteristics of MCR-1–producing E. coli and K. pneumoniae isolates and their transconjugants.

Isolates Transconjugants

Isolate Species Origin Colistin MIC, mg/L Resistance phenotype (epidemiological cut-off values of EUCAST)a Resistance phenotype (clinical breakpoints of EUCAST)b Incompatibility group (kb) of mcr-1 plasmids Colistin MIC of transconjugants mg/L Co-transferred resistance (epidemiological cut-off values of EUCAST)a Co-transferred resistance (clinical breakpoints of EUCAST)b
Poultry slaughterhouses
01/05-11 E. coli Influent in-house WWTP 8 AMP, CHL, CIP, CST, CTX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CHL, SXT, CST IncF (30) 8
01/05-12 E. coli Influent in-house WWTP 8 AMP, CHL, CIP, CST, CTX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CHL, SXT, CST IncF (30) 8
01/07-07 E. coli Stunning facilities 8 AMP, CHL, CIP, CST, CTX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CHL, SXT, CST IncX4 (30) 4 CIP, NAL
01/07-09 E. coli Stunning facilities 8 AMP, CHL, CIP, CST, CTX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CHL, SXT, CST IncI1 (30) 8 CIP, NAL
01/07-11 E. coli Stunning facilities 8 AMP, CHL, CIP, CST, CTX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CAZ, CHL, SXT, CST IncX4 (30) 4 CIP, NAL
01/07-12 E. coli Stunning facilities 8 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CHL, SXT, CST IncX4 (30) 4 CIP, NAL
01/08-08 E. coli Eviscerators 8 AMP, CHL, CIP, CST, CTX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CAZ, CHL, SXT, FOF, CST IncHI2 (30) 4 CIP, NAL
04/05-12 E. coli Influent in-house WWTP 4 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, CAZ, TET, FEP PIP, CTX, CAZ, C/T, CIP, LVX, CHL, CST IncHI2 (245) 4 AMP, CIP, CTX, CAZ
C-01/05-03 E. coli Influent in-house WWTP 4 AMP, CIP, CST, NAL, SMX, TET, TMP PIP, CIP, SXT, CST IncI1 (30) 4 AMP, SMX, TMP SXT
C-01/05-04 E. coli Influent in-house WWTP 4 AMP, CIP, CST, NAL, SMX, TET, TMP PIP, CIP, LVX, SXT, CST IncI2 (n.d.*) 4 CIP, NAL
C-01/07-02 E. coli Stunning facilities 4 AMP, CIP, CST, NAL, SMX, TET, TMP PIP, CIP, LVX, SXT, CST IncX4 (30) 4 CIP, NAL PIP, CIP, LVX, SXT
C-01/07-04 E. coli Stunning facilities 4 AMP, CIP, CST, NAL, SMX, TET, TMP PIP, CIP, LVX, SXT, CST IncX4 (30) 4 CIP, NAL
C-01/07-06 E. coli Stunning facilities 4 AMP, CIP, CST, NAL, SMX, TET, TMP PIP, SXT, CST IncX4 (30) 4 CIP, NAL
C-04/02-02 E. coli Transport crates 4 AMP, CIP, CST, NAL, SMX, TET PIP, CIP, LVX, CST IncX4 (30) 4 CIP, NAL
C-04/05-10 E. coli Influent in-house WWTP 4 AMP, CST, SMX, TET, TMP PIP, SXT, CST IncI1 (360) 4 AMP, SMX, TET, TMP PIP, SXT
C-04/05-14 E. coli Influent in-house WWTP 4 AMP, CST, SMX, TET, TMP FOF, CST IncI1 (360) 4 AMP, SMX, TET, TMP
C-04/06-02 E. coli Effluent in-house WWTP 8 AMP, CST, SMX, TMP PIP, CIP, LVX, CST IncHI2 (30) 8 AMP, SMX, TMP PIP
C-04/07-04 E. coli Stunning facilities 4 AMP, CIP, CST, SMX, NAL, TET, TMP PIP, CIP, SXT, CST IncF (215) 4 AMP, CIP, NAL, SMX, TMP SXT

Poultry slaughterhouses

C-04/07-07 E. coli Stunning facilities 4 AMP, CIP, CST, SMX, NAL, TET, TMP PIP, SXT, CST IncHI2 (215) 4 AMP, CIP, NAL, TET PIP, SXT
04/07-04 K. pneumoniae Stunning facilities 8 AMP, CIP, CST, CTX, NAL, SMX, CAZ, TET, TMP, FEP, FOX PIP, CTX, CIP, LVX, CHL, SXT, FOF, CST IncI1 (30) 4 CIP, NAL
04/07-12 K. pneumoniae Stunning facilities 8 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, CAZ, TET, FEP PIP, TZP, CTX, CAZ, CIP, LVX, CHL, SXT, FOF, CST IncX4 (85) 8 CIP, CTX, NAL, CAZ, FOX
04/07-14 K. pneumoniae Stunning facilities 16c AMP, CIP, CST, CTX, NAL, SMX, CAZ, TMP, FEP PIP, CTX, CAZ, C/T, CIP, LVX, SXT, FOF, CST IncX4 (30) 4 CIP, NAL
C-04/02-17 K. pneumoniae Transport crates >64c AMP, CST PIP, SMX, CST IncI1 (30) 8
C-04/03-01 K. pneumoniae Scalding water 16c AMP, CIP, CST, NAL CIP, LVX, CST IncX4 (30) 4 CIP, NAL

Pig slaughterhouses and mWWTPs

05/01-09 E. coli Influent in-house WWTP 8 AMP, CHL, CIP, CST, CTX, FOX, TET, TMP, FEP PIP, TZP, CTX, CIP, LVX, CHL, SMX, CST IncI1 (30) 8 TET
05/01-21 E. coli Influent in-house WWTP 8 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, TET, TMP, FEP, ETP PIP, TZP, CIP, LVX, CHL, SXT, CST IncI1 (30) 8 TET
05/01-22 E. coli Influent in-house WWTP 4 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, TET, TMP, FEP, ETP PIP, TZP, CIP, LVX, CHL, SXT, CST IncI1 (30) 4 TET
05/01-23 E. coli Influent in-house WWTP 4 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, TET, TMP, FEP, ETP PIP, TZP, CIP, LVX, CHL, SXT, CST IncI1 (30) 4 TET
05/02-28 E. coli Effluent in-house WWTP 4 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, TET, TMP, FEP, ETP PIP, TZP, CIP, LVX, CHL, SXT, CST IncI1 (30) 4 TET
05/02-29 E. coli Effluent in-house WWTP 4 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, TET, TMP, FEP, ETP PIP, TZP, CTX, CIP, LVX, CHL, SXT, CST IncI1 (30) 4 TET
05/06-69 E. coli Aggregate wastewater from producing facilities 8 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, TET, TMP, FEP, ETP PIP, TZP, CIP, LVX, CHL, SXT, CST IncI1 (30) 4 TET
05/06-70 E. coli Aggregate wastewater from producing facilities 8 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, TET, TMP, FEP, ETP PIP, TZP, CIP, LVX, CHL, SXT, CST IncI1 (30) 4 TET
C-03/01-04 E. coli Influent in-house WWTP 8 AMP, CIP, CST, NAL, SMX, TET, TMP PIP, CIP, LVX, CHL, CST IncI1 (30) 4 CIP, NAL
C-03/12-05 E. coli On-site preflooder downstream 8 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, CAZ, TET, FEP PIP, CST IncHI2 (n.d.*) 2 CIP, NAL
C-03/12-07 E. coli On-site preflooder downstream 4 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, CAZ, TET, TGC, FEP PIP, CST IncHI2 (245) 2

Poultry slaughterhouses

C-03/12-08 E. coli On-site preflooder downstream 8 AMP, CHL, CIP, CST, CTX, FOX, NAL, SMX, CAZ, TET, FEP PIP, TZP, CST IncHI2 (230) 4 CIP, NAL
C-03/05-01 K. pneumoniae Animal transporters >64c AMP, CHL, CIP, CST, NAL PIP, CIP, LVX, CHL, CST IncX4 (30) 4 CIP, NAL
C-03/08-01 K. pneumoniae Scalding water >64c AMP, CHL, CIP, CST, CTX, FOX, NAL, CAZ, FEP FOF, CST IncX4 (30) 4 CIP, NAL

aAntimicrobial Susceptibility Testing Plates of German Federal Institute for Risk Assessment (BfR) containing sulfamethoxazole (SMX), trimethoprim (TMP), chloramphenicol (CHL), ciprofloxacin (CIP), nalidixic acid (NAL), tetracycline (TET), tigecycline (TGC), ertapenem (ETP), meropenem (MEM), imipenem (IMI), cefotaxime (CTX), ceftazidime (CAZ), cefoxitin (FOX), cefepime (FEP), colistin (CST), ampicillin (AMP), gentamicin (GEN). MIC were interpreted according to the epidemiological cut off values of EUCAST. bMicronaut-S MDR MRGN-Screening system containing temocillin (TEM), piperacillin (PIP), piperacillin/tazobactam (TZP), cefotaxime (CTX), ceftazidime (CAZ), imipenem (IMI), meropenem (MEM), amikacin (AMK), tigecycline (TGC), chloramphenicol (CHL), fosfomycin (FOF), trimethoprim/sulfamethoxazole (SXT), ciprofloxacin (CIP), levofloxacin (LVX), and colistin (CST). MIC were interpreted according to the clinical breakpoints of EUCAST. cPolymorphisms found for coding sequences for PmrA or PmrB in 04/07-14: 157T→P (PmrB) and C-04/03-01: 73P→x (PmrB), 74S→x (PmrB). n.d., not detected.